Fette Pharma GmbH
Fette Pharma GmbH is a German pharmaceutical distribution company (8 employees, Egelsbach) that provides direct, GDP- and EU-GMP-certified distribution and supply chain services for international cannabis cultivators and brands seeking to enter the German medical cannabis market.
- Company typePrivate
- Founded-
- HeadquartersEgelsbach, Germany
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Fette Pharma GmbH does
Fette Pharma GmbH is a privately-held German pharmaceutical services company headquartered in Egelsbach, Germany, with a secondary operations facility in Nordhorn. The company operates as a licensed distributor and gateway for medical cannabis products into the German market, which it describes as the largest medicinal cannabis market in Europe. It holds GDP and EU-GMP certifications, which are the regulatory prerequisites for handling and distributing medical cannabis products in Germany.
The company provides an integrated service offering to international cannabis cultivators and brands seeking to enter the German market: local distribution and last-mile logistics to pharmacies, integrated supply chain management spanning GACP cultivation support through EU-GMP market introduction, and brand-building services. Its distribution model is direct-to-pharmacy, bypassing brokers and consultants, which is the primary differentiator versus competitors. The company also operates the RE:CANNIS sub-brand, positioned as a proprietary medical cannabis therapy brand in the German market.
The business model is B2B and sales-led, with revenue generated through transaction fees on direct sales and logistics services, managed services for integrated supply chain support, and professional services for brand development. The company is small, with 8 employees, and is led by two Managing Directors (Geschäftsführer): Maik Dobiey and Jörg Löser. No revenue, funding, or transaction volume is publicly disclosed. The company has no proprietary technology platform, no API, no disclosed AI capabilities, and no patents or trademarks. Its sole disclosed external partnership is a web hosting relationship with INSIGMA IT Engineering GmbH.
Fette Pharma GmbH firmographics
Firmographics- Name
- Fette Pharma GmbH
- Legal name
- Fette Pharma GmbH
- Website
- https://fette-pharma.de
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Fette Pharma GmbH is a German pharmaceutical distribution company (8 employees, Egelsbach) that provides direct, GDP- and EU-GMP-certified distribution and supply chain services for international cannabis cultivators and brands seeking to enter the German medical cannabis market.
- Ownership category
- akta.pro rank
Fette Pharma GmbH industry classification
Industry- Product category
- Pharmaceutical Distribution Services
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Cannabis Wholesale Distribution (Flower, Extracts, Edibles) (CRAOAIAF)
Keywords
Where Fette Pharma GmbH is headquartered
LocationHeadquarters
- HQ city
- Egelsbach
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
Fette Pharma GmbH business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Direct Sales & Logistics Services: Local distribution, customer care, and last-mile delivery in Germany for medical cannabis products.
- Integrated Supply Chain Services: Comprehensive services from GACP cultivation through EU-GMP market introduction, supporting partners entering the German medical cannabis market.
- Brand Building Services: Establishment and development of proprietary brands within the German medical cannabis market, the largest medicinal market in Europe.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Fette Pharma GmbH product offering
Product offeringCore offering
Fette Pharma GmbH is a licensed, GDP- and GMP-certified distribution and service provider for medical cannabis in Germany. It offers direct sales, local distribution, customer care, and last-mile delivery to the German pharmacy network, alongside integrated supply chain support from GACP cultivation through EU-GMP market introduction, and brand building services for partner brands seeking to enter the German market. Operating brands include the RE:CANNIS sub-brand, positioned as a new standard in medical cannabis therapy.
Product overview
Fette Pharma GmbH operates as a licensed distribution company for the German medical cannabis market, providing integrated services including direct sales and logistics, supply chain management from GACP cultivation to EU-GMP certification, brand development support, and direct market access without broker fees. The company distributes products under its own operational umbrella as well as through the RE:CANNIS sub-brand, which represents a medical cannabis therapy brand positioned as a new standard in the market.
Differentiator
Problem solved
Functional benefit
Brands
- RE:CANNIS: The new standard in medical cannabis therapy. A brand offering associated with Fette Pharma for medical cannabis products in the German market.
Products and services
- Cannabis Distribution Services Distribution and logistics services for medical cannabis products in the German market, including direct sales, local distribution, customer support, and last-mile delivery within Germany. Service scope spans GACP cultivation support through EU-GMP market introduction, designed for licensed cannabis cultivators and brands seeking to enter the German pharmacy channel.
- RE:CANNIS Sub-brand of Fette Pharma positioned as the new standard in medical cannabis therapy, offered through the Fette Pharma distribution network in the German market for patient dispensing.
Companies that use Fette Pharma GmbH
Customer profileSegments3 records
Ideal customer profiles3 records
Fette Pharma GmbH technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Fette Pharma GmbH partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- RE:CANNIScoreRE:CANNIS is a brand under Fette Pharma representing the new standard in medical cannabis therapy. It is positioned as a key product/brand offering in the company's portfolio for the German medical cannabis market.
Scale indicators1 record
Recent moves6 records
Expansion highlights3 records
Fette Pharma GmbH competitors and assessment
Company assessmentBroad incumbents
- Sanity Group GmbH: Berlin-based cannabis company spanning medical and consumer segments, with distribution and brand activities in Germany. Broader incumbent operating across multiple cannabis verticals.
- Demecan GmbH: Vertically integrated German medical cannabis cultivator and distributor. Comparable as a domestic player covering cultivation-to-pharmacy flow, but operates its own cultivation rather than being purely distribution-led.
- Aurora Europe GmbH (Aurora Cannabis): European arm of a major Canadian cannabis producer with German market presence and EU-GMP supply. Comparable as a large upstream supplier/cultivator whose products can flow through Fette Pharma's distribution channel.
Direct peers
- Cannamedical Pharma GmbH: Cologne-based medical cannabis wholesaler serving German pharmacies with EU-GMP product. Direct competitor on the wholesale-distribution-to-pharmacy model.
- Four 20 Pharma GmbH: German medical cannabis distributor/brand owner supplying pharmacies across Germany. Comparable as a domestic peer combining distribution and own-brand activity in the same regulated channel.
- Cansativa GmbH: German medical cannabis wholesale distributor operating a direct-to-pharmacy platform. Directly comparable to Fette Pharma on customer (pharmacies), product (medical cannabis), and B2B distribution model in Germany.
- Lexamed GmbH: German medical cannabis wholesale distributor serving pharmacies. Direct competitor on regulatory-certified B2B distribution into the German pharmacy network.
- Nimbus Health GmbH: German medical cannabis distributor with pharmacy delivery network. Comparable as a domestic cannabis wholesaler targeting the same regulated pharmacy channel.
Emerging players
- avaay GmbH: German medical cannabis brand/distributor combining own-brand and B2B supply to pharmacies. Comparable as a younger peer also pairing brand-building with pharmacy-channel distribution.
Others
- Storz & Bickel GmbH: German manufacturer of medically certified vaporizers used in cannabis therapy. Adjacent to Fette Pharma's end-market (medical cannabis patients) but operates in devices rather than distribution.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat2 records
Key risks6 records
Key highlights6 records
Customer concentration
Fette Pharma GmbH social profiles
Digital presenceFette Pharma GmbH compliance and trust
Trust signalCompliance2 records
Fette Pharma GmbH financial estimates
Financial estimateRevenue estimate
Valuation estimate
Fette Pharma GmbH leadership team
Management profileNumber of profiles
Profiles2 records
Fette Pharma GmbH funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Fette Pharma GmbH M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Fette Pharma GmbH
What does Fette Pharma GmbH do?
Fette Pharma GmbH is a licensed, GDP- and GMP-certified distribution and service provider for medical cannabis in Germany. It offers direct sales, local distribution, customer care, and last-mile delivery to the German pharmacy network, alongside integrated supply chain support from GACP cultivation through EU-GMP market introduction, and brand building services for partner brands seeking to enter the German market. Operating brands include the RE:CANNIS sub-brand, positioned as a new standard in medical cannabis therapy.
Is Fette Pharma GmbH a public or private company?
Fette Pharma GmbH is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Fette Pharma GmbH founded?
Fette Pharma GmbH was founded in -1. It employs 1 to 10 people.
Where is Fette Pharma GmbH based?
Fette Pharma GmbH is headquartered in Egelsbach, Germany, in the Europe region.
How does Fette Pharma GmbH make money?
Three revenue lines are on record. Direct Sales & Logistics Services are the primary driver. The others are integrated Supply Chain Services and brand Building Services.
Who are Fette Pharma GmbH's main competitors?
Broad incumbents on record are Sanity Group GmbH, Demecan GmbH and Aurora Europe GmbH (Aurora Cannabis). Direct peers are Cannamedical Pharma GmbH, Four 20 Pharma GmbH, Cansativa GmbH, Lexamed GmbH and Nimbus Health GmbH. avaay GmbH is listed as an emerging player. Storz & Bickel GmbH is listed as an others.
Does Fette Pharma GmbH have an API?
No public API is recorded for Fette Pharma GmbH.
What industry is Fette Pharma GmbH in?
Fette Pharma GmbH's product category is Pharmaceutical Distribution Services. Its primary akta.pro industry code is CRAOAIAF, Cannabis Wholesale Distribution (Flower, Extracts, Edibles). Its NAICS code is 424210 and its SIC code is 5122.